698 related articles for article (PubMed ID: 29524020)
1. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
2. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
3. Cross-Dysregulation of
Very N; Vercoutter-Edouart AS; Lefebvre T; Hardivillé S; El Yazidi-Belkoura I
Front Endocrinol (Lausanne); 2018; 9():602. PubMed ID: 30356686
[TBL] [Abstract][Full Text] [Related]
4. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
5. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
Issad T; Al-Mukh H; Bouaboud A; Pagesy P
J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
7. O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress.
Butkinaree C; Park K; Hart GW
Biochim Biophys Acta; 2010 Feb; 1800(2):96-106. PubMed ID: 19647786
[TBL] [Abstract][Full Text] [Related]
8. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells.
Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T
Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mTOR affects protein stability of OGT.
Park S; Pak J; Jang I; Cho JW
Biochem Biophys Res Commun; 2014 Oct; 453(2):208-12. PubMed ID: 24858682
[TBL] [Abstract][Full Text] [Related]
11. Moderate mammalian target of rapamycin inhibition induces autophagy in HTR8/SVneo cells via O-linked β-N-acetylglucosamine signaling.
Zhang Q; Na Q; Song W
J Obstet Gynaecol Res; 2017 Oct; 43(10):1585-1596. PubMed ID: 28691313
[TBL] [Abstract][Full Text] [Related]
12. Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling.
Cork GK; Thompson J; Slawson C
Front Endocrinol (Lausanne); 2018; 9():522. PubMed ID: 30237786
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
14. Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Nagel AK; Ball LE
Adv Cancer Res; 2015; 126():137-66. PubMed ID: 25727147
[TBL] [Abstract][Full Text] [Related]
15. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
[TBL] [Abstract][Full Text] [Related]
16. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Kim G; Cao L; Reece EA; Zhao Z
Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244
[TBL] [Abstract][Full Text] [Related]
17. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
Le Minh G; Reginato MJ
Adv Cancer Res; 2023; 157():195-228. PubMed ID: 36725109
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
[TBL] [Abstract][Full Text] [Related]
19. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
Isono T
PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]